- Incidence and management of gastrointestinal perforation from bevacizumab in advanced cancersTaher Abu-Hejleh
Department of Internal Medicine, Division of Hematology, Oncology, and Bone Marrow Transplantation, The University of Iowa Hospitals and Clinics, 200 Hawkins Dr, C32 GH, Iowa City, IA 52242 1081, USA
Curr Oncol Rep 14:277-84. 2012..The management of bevacizumab-induced bowel perforation depends on the clinical presentation and the goals of care set by the treating physicians and the patient...
- Advances in the systemic treatment of leptomeningeal cancerTaher Abu Hejleh
Division of Hematology, Oncology and Marrow Transplantation, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, Iowa 52242 1081, USA
Clin Adv Hematol Oncol 10:166-70. 2012..In this article, we review the history of the major therapeutic approaches used to treat LMC, and we expand on the promising new venues for applying biologic targeted agents to the treatment options utilized in LMC...